New recommendations in prostate cancer screening and treatment

被引：4

作者：

Adams, Lisa K. ^{[1
,2
]}

Ferrington, Lindsay S. ^{[3
]}

机构：

[1] Feist Weiller Canc Ctr, Practices Hematol Oncol, Shreveport, LA 71103 USA

[2] Louisiana State Univ, Hlth Sci Ctr, Recent Grad PA Program, Shreveport, LA 71105 USA

[3] Louisiana State Univ, PA Program, Shreveport, LA 71105 USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2014年 / 27卷 / 08期

关键词：

prostate cancer; prostate-specific antigen; Gleason score; vaccine; screening; androgen deprivation therapy; SKELETAL-RELATED EVENTS; RISK; MEN; ANTIGEN; STATISTICS; GUIDELINES; MANAGEMENT; OUTCOMES;

D O I：

10.1097/01.JAA.0000451872.86566.bf

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Prostate cancer is the most commonly diagnosed nonskin cancer in men, with 233,000 new cases estimated for 2014. Nearly 30,000 deaths are predicted for 2014, second only to lung and bronchial cancer deaths. Early diagnosis is key to improving patient survival rates. Screening efforts have dramatically increased the detection rate, and now, 90% of new diagnoses are caught at the early stage of disease. However, new data are driving controversial changes to screening and treatment recommendations.

引用

页码：14 / 20

页数：7

共 38 条

[11] Screening for Prostate Cancer: A Review of the Evidence for the US Preventive Services Task Force [J].

Chou, Roger ;

Croswell, Jennifer M. ;

Dana, Tracy ;

Bougatsos, Christina ;

Blazina, Ian ;

Fu, Rongwei ;

Gleitsmann, Ken ;

Koenig, Helen C. ;

Lam, Clarence ;

Maltz, Ashley ;

Rugge, J. Bruin ;

Lin, Kenneth .

ANNALS OF INTERNAL MEDICINE, 2011, 155 (11) :762-U94

[12] The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management [J].

Cooperberg, MR ;

Lubeck, DP ;

Meni, MV ;

Mehta, SS ;

Carroll, PR .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2141-2149

[13]

Dahabreh IJ, 2012, ANN INTERN MED, V156, P582, DOI [10.7326/0003-4819-156-8-201204170-00009, 10.7326/0003-4819-156-8-201204170-00397]

[14] When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool [J].

De Nunzio, Cosimo ;

Leonardo, Costantino ;

Franco, Giorgio ;

Esperto, Francesco ;

Brassetti, Aldo ;

Simonelli, Giovanni ;

Dente, Dino ;

De Dominicis, Carlo ;

Tubaro, Andrea .

WORLD JOURNAL OF UROLOGY, 2013, 31 (02) :365-369

[15]

Drudge-Coates Lawrence, 2012, Br J Nurs, V21, pS23

[16]

Gomella LG, 2011, CAN J UROL, V18, P5875

[17] Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group [J].

Grimm, Peter ;

Billiet, Ignace ;

Bostwick, David ;

Dicker, Adam P. ;

Frank, Steven ;

Immerzeel, Jos ;

Keyes, Mira ;

Kupelian, Patrick ;

Lee, W. Robert ;

Machtens, Stefan ;

Mayadev, Jyoti ;

Moran, Brian J. ;

Merrick, Gregory ;

Millar, Jeremy ;

Roach, Mack ;

Stock, Richard ;

Shinohara, Katsuto ;

Scholz, Mark ;

Weber, Ed ;

Zietman, Anthony ;

Zelefsky, Michael ;

Wong, Jason ;

Wentworth, Stacy ;

Vera, Robyn ;

Langley, Stephen .

BJU INTERNATIONAL, 2012, 109 :22-29

[18] Focal cryosurgical ablation of the prostate: a single institute's perspective [J].

Hale, Zachary ;

Miyake, Makito ;

Palacios, Diego Aguilar ;

Rosser, Charles J. .

BMC UROLOGY, 2013, 13

[19] Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401 [J].

Kelly, William Kevin ;

Halabi, Susan ;

Carducci, Michael ;

George, Daniel ;

Mahoney, John F. ;

Stadler, Walter M. ;

Morris, Michael ;

Kantoff, Philip ;

Monk, J. Paul ;

Kaplan, Ellen ;

Vogelzang, Nicholas J. ;

Small, Eric J. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) :1534-1540

[20]

Lieberman Ronald, 2004, Am J Ther, V11, P501

← 1 2 3 4 →